Molecule Structure

Scientific Name

Midazolam

Description of the Drug

Midazolam is a short-acting benzodiazepine with rapid onset that is commonly used in seizures, anesthesia and anxiety disorders.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00683

Brand Name(s)

Midazolam in 0.8% sodium chloride, Midazolam in 0.9% sodium chloride, Nayzilam

Company Owner(s)

Inforlife Sa, Igi Laboratories Inc, Atlantide Pharmaceuticals Ag, Akorn Operating Co Llc, Hikma Pharmaceuticals International Ltd, Bedford Laboratories Div Ben Venue Laboratories Inc, Meridian Medical Technologies Llc, Fresenius Kabi Usa Llc, Steriscience Pte Ltd, Apothecon Inc Div Bristol Myers Squibb

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
GABA-A receptor; anion channel PROTEIN COMPLEX GROUP POSITIVE ALLOSTERIC MODULATOR CHEMBL2093872

Unichem Links

SureChEMBL SCHEMBL35061
PharmGKB PA450496
Human Metabolome Database HMDB0014821
DrugBank DB00683
PubChem: Thomson Pharma 14850779
PubChem 4192
LINCS LSM-5200
Nikkaji J31.859K
PDBe 08J
BindingDB 21363
EPA CompTox Dashboard DTXSID5023320
DrugCentral 1802
Brenda 145058 12205 145972
ChemicalBook CB0418580
Guide to Pharmacology 3342
rxnorm MIDAZOLAM MALEATE MIDAZOLAM SEIZALAM MIDAZOLAM HYDROCHLORIDE NAYZILAM
KEGG Ligand C07524
ChEBI 6931
ZINC ZINC000095626706